EFFECT OF ONCE-WEEKLY RIFAPENTINE AND ISONIAZID ON THE PHARMACOKINETICS OF TWICE-DAILY DORAVIRINE IN HEALTHY VOLUNTEERS.

被引：0
|
作者：
Lam, E. [1 ]
Zheng, R. [1 ]
Schaefer, J. [2 ]
Kraft, W. [1 ]
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Sidney Kimmel Med Coll, Philadelphia, PA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-009
引用
收藏
页码：S81 / S81
页数：1
相关论文
共 50 条
  • [1] EFFECT OF ONCE-WEEKLY RIFAPENTINE AND ISONIAZID ON THE PHARMACOKINETICS OF TWICE-DAILY DORAVIRINE IN HEALTHY VOLUNTEERS.
    Lam, E.
    Zheng, R.
    Schaefer, J.
    Kraft, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S6 - S6
  • [2] Twice-Daily Doravirine Overcomes the Interaction Effect from Once-Weekly Rifapentine and Isoniazid in Healthy Volunteers
    Lam, Edwin
    Schaefer, Joseph
    Zheng, Richard
    Zhan, Tingting
    Kraft, Walter K.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (06): : 1244 - 1250
  • [3] Role of isoniazid in once-weekly rifapentine treatment of pulmonary tuberculosis
    Mitchison, DA
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (10) : 1298 - 1299
  • [4] Safety and tolerability for once-weekly Rifapentine plus Isoniazid in Taiwan
    Chan, Pei-Chun
    Lee, Pin-Hui
    Lu, Min-Ju
    Huang, You-Chieh
    Huang, Shu-Hua
    Huang, Yen-Fang
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S159 - S160
  • [5] Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine
    Weiner, M
    Burman, W
    Vernon, A
    Benator, D
    Peloquin, CA
    Khan, A
    Weis, S
    King, B
    Shah, N
    Hodge, T
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (10) : 1341 - 1347
  • [6] Pharmacokinetics, Safety, and Tolerability of Once-Daily Darunavir With Cobicistat and Weekly Isoniazid/Rifapentine
    Brooks, Kristina M.
    Pau, Alice K.
    Swaim, Doris
    Bunn, Haden T.
    Adeojo, Lilian
    Peloquin, Charles A.
    Kumar, Parag
    Kovacs, Joseph A.
    George, Jomy M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2023, 94 (05) : 468 - 473
  • [7] Clinical Implications of Exenatide as a Twice-Daily or Once-Weekly Therapy for Type 2 Diabetes
    Aroda, Vanita R.
    DeYoung, Mary Beth
    POSTGRADUATE MEDICINE, 2011, 123 (05) : 228 - 238
  • [8] Early Predictors of Response to Exenatide Twice-Daily (BID) and Once-Weekly (QW) Therapy
    Blonde, Lawrence
    Wysham, Carol H.
    Malloy, Jaret
    Han, Jenny
    DIABETES, 2014, 63 : A256 - A257
  • [9] STEADY-STATE PHARMACOKINETICS AND TOLERABILITY OF ONCE-DAILY AND TWICE-DAILY REGIMENS OF ESLICARBAZEPINE ACETATE IN HEALTHY VOLUNTEERS
    Vaz-Da-Silva, M.
    Falcao, A.
    Nunes, T.
    Almeida, L.
    Soares-Da-Silva, P.
    EPILEPSIA, 2012, 53 : 119 - 119
  • [10] Evaluation of 3 Months of Once-Weekly Rifapentine and Isoniazid for Latent Tuberculosis Infection
    Walker, Ramara E.
    Bass, Stephanie
    Srinivas, Pavithra
    Miranda, Cyndee
    Johnson, Lucileia
    Pallotta, Andrea M.
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (05) : 457 - 463
12345